AMENDMENT TO AMENDED AND RESTATEDEmployment Agreement • March 9th, 2017 • Aerie Pharmaceuticals Inc • Biological products, (no disgnostic substances)
THIS AMENDMENT TO THE AMENDED AND RESTATED EMPLOYMENT AGREEMENT, dated as of March 6, 2017 (the “Amendment”), by and between Aerie Pharmaceuticals, Inc., a Delaware corporation (the “Company”) and Richard Rubino (the “Executive”).
AMENDMENT TO AMENDED AND RESTATEDEmployment Agreement • March 9th, 2017 • Aerie Pharmaceuticals Inc • Biological products, (no disgnostic substances)
THIS AMENDMENT TO THE AMENDED AND RESTATED EMPLOYMENT AGREEMENT, dated as of March 6, 2017 (the “Amendment”), by and between Aerie Pharmaceuticals, Inc., a Delaware corporation (the “Company”) and Thomas Mitro (the “Executive”).
AERIE PHARMACEUTICALS, INC. INDUCEMENT AWARD PLAN RESTRICTED STOCK AGREEMENTInducement Award Plan • March 9th, 2017 • Aerie Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Delaware
THIS AGREEMENT (this “Agreement”) effective as of the date of grant set forth on the signature page hereto (the “Date of Grant”), is between Aerie Pharmaceuticals, Inc., a Delaware corporation (together with its successors, the “Company”), and the individual whose name is set forth on the signature page hereto (the “Grantee”).
FIRST AMENDMENT TO NOTE PURCHASE AGREEMENTNote Purchase Agreement • March 9th, 2017 • Aerie Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
THIS FIRST AMENDMENT TO NOTE PURCHASE AGREEMENT (this “Amendment”), dated as of December 28, 2016, is entered into by and among AERIE PHARMACEUTICALS, INC., a Delaware corporation (“Borrower”), and DEERFIELD PRIVATE DESIGN FUND III, L.P., DEERFIELD INTERNATIONAL MASTER FUND, L.P., DEERFIELD PARTNERS, L.P. and DEERFIELD SPECIAL SITUATIONS FUND, L.P. (collectively referred to as the “Purchasers,” and together with the Borrower, the “Parties”).
AERIE PHARMACEUTICALS, INC. INDUCEMENT AWARD PLAN FORM OF NONQUALIFIED STOCK OPTION AGREEMENTNonqualified Stock Option Agreement • March 9th, 2017 • Aerie Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Delaware
Aerie Pharmaceuticals, Inc., a Delaware corporation (the “Company”), hereby grants to the individual named below an option (the “Option”) to purchase a number of shares of common stock of the Company pursuant to the Aerie Pharmaceuticals, Inc. Inducement Award Plan, in the manner and subject to the provisions of this Option Agreement. Except as otherwise defined herein, capitalized terms used in this Option Agreement shall have the same definitions as set forth in the Plan.
EMPLOYMENT AGREEMENTEmployment Agreement • March 9th, 2017 • Aerie Pharmaceuticals Inc • Biological products, (no disgnostic substances)
THIS AMENDMENT TO THE EMPLOYMENT AGREEMENT, dated as of March 6, 2017 (the “Amendment”), by and between Aerie Pharmaceuticals, Inc., a Delaware corporation (the “Company”) and Casey Kopczynski (the “Executive”).
